Adverse skin lesions after methylene blue injections for sentinel lymph node localization.

@article{Stradling2002AdverseSL,
  title={Adverse skin lesions after methylene blue injections for sentinel lymph node localization.},
  author={Benjamin Stradling and Gerard V. Aranha and Sheryl Gabram},
  journal={American journal of surgery},
  year={2002},
  volume={184 4},
  pages={350-2}
}
BACKGROUND Methylene blue dye (MBD) is being used as an alternative to isosulfan blue dye in sentinel lymph node (SLN) biopsies for breast cancer patients. Complications using MBD for SLN localization have not previously been reported. METHODS A retrospective study was conducted of 24 consecutive patients who received MBD. Patients were given 3 to 5 cc of 1% MBD as peritumoral injections within the breast parenchyma and intradermally. Patients who developed local skin lesions at the injection… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 36 extracted citations

Similar Papers

Loading similar papers…